F2R and pachyonychia congenita: Neuropeptides, notably bombesin were also found to enhance early growth response 1 (Egr-1) expression leading to increased human protease-activated receptor 1 (PAR1) expression and function directly correlating with invasiveness and the degree of PC malignancy (39).